Our data suggest that endogenous eNOS/nNOS activity in ovarian cancer cells, especially CDDP-resistant cells, produces low-level NO that protects them against induction of apoptosis, thus contributing to resistance against CDDP. The gene discussed is NOS1; the disease is ovarian cancer.